...
首页> 外文期刊>Arzneimittel-Forschung: =Drug Research >Protein- and lipid modification of natural bovine surfactant. Effects in experimental lung failure with special consideration of the response in neonates.
【24h】

Protein- and lipid modification of natural bovine surfactant. Effects in experimental lung failure with special consideration of the response in neonates.

机译:天然牛表面活性剂的蛋白质和脂质修饰。特殊考虑新生儿的反应对实验性肺衰竭的影响。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Surfactant therapy does not lead to a uniform, optimal and sustained effect on gas exchange in neonatal respiratory distress syndrome (RDS) and acute respiratory distress syndrome (ARDS). The aim of the present study therefore was to compare the effects of a lipid-enriched and protein-modified natural surfactant preparations with a licensed, clinically used bovine surfactant preparation - SF-Ril (Alveofact). METHODS: SF-Ril was enriched with phosphatidylglycerol, sphingomyeline, phosphatidylethanolamine plasmalogen, phosphatidylethanolamine. Furthermore, SF-Ril was modified with increased surfactant protein B (SP-B)/surfactant protein C (SP-C) content and finally a mercaptoethanol (ME) treated preparation for breaking the sulfhydril bondage of SP-B/SP-C by chemical reduction in methylene chloride using ME was developed. Finally ME was removed by vacuum extraction. These modified surfactants were tested at a dosage of 100 mg/ kg each in a model of respiratory failure induced by lung lavage in male adult rats and compared with SF-Ril at an identical dosage. Mechanical ventilation was standardised with fraction of inspiratory oxygen (FiO2) 1.0 and time-cycled pressure limited ventilation 16/0.8 cmH2O before and 26/6 cmH2O (peak inspiratory pressure/positive endexpiratory pressure) after lung lavage (target arterial oxygen pressure [pa02] < 100 mmHg), respiratory rate 36/min, inspiration/expiration time ratio 1:2. RESULTS: During the observation period of 120 min, the sphingomyeline substituted and protein-modified (ME reduced) surfactant preparations exerted improved and sustained oxygenation compared with SF-Ril. Similar effects were observed for tidal volumes. All other preparations were equal or inferior to SF-Ril in our model. CONCLUSION: For the development of surfactant preparations less prone for inactivation the above mentioned data may provide useful information, provided they can be confirmed in further investigations employing other alternative models.
机译:在新生儿呼吸窘迫综合征(RDS)和急性呼吸窘迫综合征(ARDS)中,表面活性剂治疗不会对气体交换产生统一,最佳和持续的影响。因此,本研究的目的是比较富含脂质和蛋白质修饰的天然表面活性剂制剂与经许可的临床使用的牛表面活性剂制剂SF-Ril(Alveofact)的效果。方法:SF-Ril富含磷脂酰甘油,鞘氨醇,磷脂酰乙醇胺缩醛磷脂,磷脂酰乙醇胺。此外,用增加的表面活性剂蛋白B(SP-B)/表面活性剂蛋白C(SP-C)含量修饰SF-Ril,最后用巯基乙醇(ME)处理的制剂通过以下方法破坏SP-B / SP-C的巯基键合:开发了使用ME的二氯甲烷化学还原方法。最后,通过真空萃取除去ME。在雄性成年大鼠的肺灌洗诱导的呼吸衰竭模型中,以100 mg / kg的剂量分别测试了这些改性的表面活性剂,并与相同剂量的SF-Ril进行了比较。机械通气标准化为吸氧分数(FiO2)1.0和限时通气在肺灌洗之前为16 / 0.8 cmH2O,洗肺后为26/6 cmH2O(峰值吸气压力/呼气末正压)(目标动脉氧压[pa02]) <100 mmHg),呼吸频率36 / min,吸气/呼气时间比1:2。结果:在120分钟的观察期内,鞘磷脂取代和蛋白质修饰(ME还原)的表面活性剂制剂与SF-Ril相比具有改善和持续的氧合作用。对于潮气量也观察到类似的效果。在我们的模型中,所有其他制剂均与SF-Ril相同或劣于SF-Ril。结论:对于开发不易失活的表面活性剂制剂,上述数据可提供有用的信息,只要可以在采用其他替代模型的进一步研究中加以证实。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号